

Facile synthesis and cytotoxic activity of 3,6-disubstituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazoles
Kaliappan Ilango (1,*)


(1) Department of Pharmaceutical Chemistry, College of Pharmacy, Sri Ramasamy Memorial University, Kattankulathu, TN-603203, India.
(2) Department of Pharmaceutical Chemistry, College of Pharmacy, Sri Ramasamy Memorial University, Kattankulathu, TN-603203, India.
(*) Corresponding Author
Received: 24 Mar 2010 | Accepted: 24 Mar 2010 | Published: 31 Mar 2010 | Issue Date: March 2010
Abstract
Afacile synthesis of 3,6-disubstituted-1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazoles (5a-j) has been achieved by condensing 3-aryl substituted 4-amino-5-mercapto (4H)-1,2,4-triazole (4a-b) with various aromatic acids. The structures of the synthesized compounds were supported by IR, 1H NMR, mass spectral data and elemental analysis The compounds were evaluated for in vitro cytotoxic activity against four human cancer cell lines: two ovarian (PA-1and OAW-42) and two breast (T47D and MCF-7) cell lines using the methyl thiazol tetrazolium assay method. It showed that some of the tested compounds 5a, 5b, 5g and 5f exhibited significant activity against PA-1 cell lines and the compounds 5a and 5e exhibited IC50 of 0.72 µM and 0.65 µM, respectively, against the cell lines of MCF-7, which are close to Doxorubin. After comparing the cytotoxic activity results of compounds 5a-j, it was concluded that the incorporation of triazolo-thiadiazole moiety in aryl propionic acid group gives rise to enhanced anticancer activity. Also, the substitution of chloro group in the aryl ring at the 3rd position was found to enhance their potency.
Keywords
Full Text:
PDF

DOI: 10.5155/eurjchem.1.1.50-53.4
Links for Article
| | | | | | |
| | | | | | |
| | |
Related Articles
Article Metrics


Citations
[1]. Saghir Abbas, Sumera Zaib, Shafiq Ur Rahman, Saqib Ali, Shahid Hameed, Muhammad N. Tahir, Khurram S. Munawar, Farzana Shaheen, Syed M. Abbas, Jamshed Iqbal
Carbonic Anhydrase Inhibitory Potential of 1,2,4-triazole-3-thione Derivatives of Flurbiprofen, Ibuprofen and 4-tert-butylbenzoic Hydrazide: Design, Synthesis, Characterization, Biochemical Evaluation, Molecular Docking and Dynamic Simulation Studies
Medicinal Chemistry 15(3), 298, 2019
DOI: 10.2174/1573406414666181012165156

[2]. Sattar Ebrahimi
Synthesis of some pyridyl and cyclohexyl substituted 1,2,4 triazole, 1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives
European Journal of Chemistry 1(4), 322, 2010
DOI: 10.5155/eurjchem.1.4.322-324.65

[3]. Georgios Charitos, Dimitrios T. Trafalis, Panayiotis Dalezis, Constantinos Potamitis, Vasiliki Sarli, Panagiotis Zoumpoulakis, Charalambos Camoutsis
Synthesis and anticancer activity of novel 3,6-disubstituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives
Arabian Journal of Chemistry 12(8), 4784, 2019
DOI: 10.1016/j.arabjc.2016.09.015

[4]. A. S. Avakyan, S. O. Vartanyan, A. B. Sargsyan
Synthesis of new 4-amino-5-(1,4-benzodioxan-2-yl)-4H-1,2,4-triazole-3-thiol derivatives
Russian Journal of Organic Chemistry 53(3), 428, 2017
DOI: 10.1134/S1070428017030198

[5]. Pooja R. Kamath, Dhanya Sunil, Shubhankar Das, Abdul Ajees Abdul Salam, B.S. Satish Rao
Efficient T3P ® mediated synthesis, differential cytotoxicity and apoptosis induction by indolo-triazolo-thiadiazoles in human breast adenocarcinoma cells
Chemico-Biological Interactions 268, 53, 2017
DOI: 10.1016/j.cbi.2017.02.011

[6]. Parthiban Valentina, Kaliappan Ilango, Muthu K. Kathiravan
Novel hybrids of drug with bioactive heterocycles for enhancing biological activity
Archives of Pharmacal Research 39(10), 1382, 2016
DOI: 10.1007/s12272-016-0797-6

[7]. Sayed M. Riyadh, Sobhi M. Gomha
Two decades of the synthesis of mono- and bis-aminomercapto[1,2,4]triazoles
RSC Advances 10(42), 24994, 2020
DOI: 10.1039/D0RA04208K

[8]. Gülsüm Gündoğdu, Sevim Peri Aytaç, Melanie Müller, Birsen Tozkoparan, Filiz Betül Kaynak
Structure determination of two structural analogs, named 3-[1-(2-fluoro-4-biphenyl)ethyl]-6-(4-fluorophenyl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole (C23H16F2N4S) and 3-[1-(2-fluoro-4-biphenyl)ethyl]-6-(4-chlorophenyl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole (C23H16ClFN4S) by synchrotron X-ray powder diffraction
Powder Diffraction 32(4), 279, 2017
DOI: 10.1017/S0885715617001105

[9]. S. A. El‐Sebaey
Recent Advances in 1,2,4‐Triazole Scaffolds as Antiviral Agents
ChemistrySelect 5(37), 11654, 2020
DOI: 10.1002/slct.202002830

References
[1]. Hill, D. L. Cancer Chemother. Pharmacol. 1980, 4, 215-220.
PMid:7002341
[2]. Nelson, J. A.; Rose, L. M.; Benette, L. Cancer Res. 1977, 37, 182-187.
PMid:187332
[3]. Tsukamoto, K.; Suno, M.; Igarashi, K.; Kozai, Y.; Sugino, Y. Cancer Res. 1975, 35, 2631-2636.
PMid:125625
[4]. Goswami, B. N.; Kattaky, J. C. S.; Baruah, J. N. J. Hetercyclic. Chem. 1984, 21, 1225-1229.
doi:10.1002/jhet.5570210460
[5]. Khan, R. H.; Srivastava, R. A. K.; Rastogi, R. C. Indian J. Pharm. Sciences. 1987, 49(2), 48-51.
[6]. Allen, L. B.; Huffmann, J. H.; Sidwell, R. W. Antimicro. Ag. Chemother. 1973, 3, 534-535.
PMid:4790608 PMCid:444450
[7]. Sabrina, B. F.; Marilia, S. C.; Nubia, B. J. S. B.; Marcelo, S. G.; Marlene, M. C.; Warner, B. K.; Vitro, F. F. Eur. J. Med. Chem. 2007, 42, 1388-1395.
doi:10.1016/j.ejmech.2007.02.020
PMid:17445951
[8]. Hart, C. Am. Chem. Soc. 1999, 2, 20-31.
[9]. David, W. A.; Thomas. L. L., Foye’s Principles of Medicinal Chemistry, Fifth ed., Lippincott Williams & Wilkins. London.
[10]. Karabasanagouda, T.; Adhikari, A. V.; Suchethasettey, N. Eur. J. Med. Chem. 2007, 42, 521-529
doi:10.1016/j.ejmech.2006.10.010
PMid:17156898
[11]. Demirbas, N.; Demibras, A.; Karaoglu, S. A.; Celik, E. Arkivoc. 2005, 1, 75-91.
[12]. Invidiata, F. P.; Simoni, D.; Scintu, F.; Pinna, N. Farmaco. 1996, 51, 659-664.
PMid:8981756
[13]. El Khawass, S. M.; Khalli, M. A.; Hazza, A. A.; Bassiouny, A.; Loutfy, N. F. Farmaco. 1989, 44, 703-709.
PMid:2590368
[14]. Al-Masoudi, N. A.; Al-Soud, Y. A. Nucleos. Nucleot. Nucleic. Acids. 2008, 27, 1034-1044.
doi:10.1080/15257770802271771
PMid:18711666
[15]. Amir, M.; Harish, K.; Javed, S. A. Eur. J. Med. Chem. 2008, 43, 2056-2066.
doi:10.1016/j.ejmech.2007.09.025
PMid:18023930
[16]. Guniz Kuchkguzel, S.; Ilkay, K.; Esra, T.; Selvim, R.; Fikrettin, S.; Medine, G.; Erik, D. C.; Levent, K. Eur. J. Med. Chem. 2007, 42, 893-901.
doi:10.1016/j.ejmech.2006.12.038
PMid:17418454
[17]. Amir, M.; Kumar, H.; Javed, S. A. Bioorg. Med. Chem. Lett. 2007, 17, 4504-4508.
doi:10.1016/j.bmcl.2007.06.003
[18]. Jeffrey, M. E.; Linda, S. A.; Andrew, O. M. Meth. Cell Sci. 2005, 11, 15-17.
How to cite
The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item
DOI Link: https://doi.org/10.5155/eurjchem.1.1.50-53.4

















European Journal of Chemistry 2010, 1(1), 50-53 | doi: https://doi.org/10.5155/eurjchem.1.1.50-53.4 | Get rights and content
Refbacks
- There are currently no refbacks.
Copyright (c)
© Copyright 2010 - 2021 • Atlanta Publishing House LLC • All Right Reserved.
The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.
Copyright 2010-2021 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.